WebMD Article Announcing FDA Approval of Obesity Drug Qsymia Warns of Dangers of Topamax Side Effects, the Consumer Justice Foundation Reports

Share Article

The Consumer Justice Foundation, a for-profit corporation whose team of professional consumer advocates provides free online educational resources to the public with regards to the potential dangers of certain prescription medications, has a Web site URL of http://topamaxbirthinjury.com. The Consumer Justice Foundation hereby alerts the public of an article recently published by WebMD that announces FDA approval for the obesity drug known as Qsymia, and the article provides a warning to some potential users of the drug of the potential dangers of Topamax side effects.

The Consumer Justice Foundation, a for-profit corporation whose team of professional consumer advocates provides free online informational resources to the public with regards to the possible dangers encountered by using certain prescription medications, hereby alerts the public of a recent article published by WebMD regarding the FDA approval for the obesity drug Qsymia. This article also contains information regarding warnings of dangers of Topamax side effects for some who may use this obesity medication.

Specifically, the article was published on July 17, 2012 on the WebMD Web site. It was written by Salynn Boyles and it is entitled, “FDA Approves Diet Drug Qsymia - Agency Warns of Increased Risk for Oral Birth Defects.” The article states that Qsymia, which is an obesity medication that is intended to be used in conjunction with a program of exercise and a healthy diet, contains Topamax.

Topamax is known as an anticonvulsant medication that has traditionally been used to treat the symptoms of epileptic seizures and migraine headaches. Its active ingredient, topiramate, is being used as part of the makeup of Qsymia. As the article goes on to state that women who are thinking of using Qsymia and who could become pregnant are advised to use strong birth control methods as well as to have a negative pregnancy test result confirmed before beginning the use of this obesity medication.

The reason for these recommendations is because, as the article states, Topamax side effects have been alleged in the past by women who have used the anticonvulsant medication during the early stages of pregnancy. These alleged Topamax side effects included those women having children who were born with a cleft lip and/or a cleft palate.

About the Consumer Justice Foundation

The Consumer Justice Foundation, whose Web site can be found at http://www.consumerjusticefoundation.com, is a for-profit organization that serves two purposes for consumers: (1) to provide educational information regarding the policies and procedures of large corporations and how they affect the average consumer; and (2) to provide news updates and resources that continue to update consumers regarding developments taken by corporations that include pharmaceutical drug companies, auto manufacturers and insurance companies so that consumers who have been harmed can use these informational resources to connect to an experienced professional who can help them. The team at the Consumer Justice Foundation is staffed by experienced and passionate consumer advocates whose mission is to raise the awareness of issues that could pose a risk of harm to those who may not otherwise be aware of the dangers they face.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Faith Anderson
Visit website